"Levofloxacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The L-isomer of Ofloxacin.
| Descriptor ID |
D064704
|
| MeSH Number(s) |
D03.633.100.810.835.322.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Levofloxacin".
Below are MeSH descriptors whose meaning is more specific than "Levofloxacin".
This graph shows the total number of publications written about "Levofloxacin" by people in this website by year, and whether "Levofloxacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 6 | 5 | 11 |
| 2018 | 7 | 13 | 20 |
| 2019 | 3 | 5 | 8 |
| 2020 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Levofloxacin" by people in Profiles.
-
The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)-preliminary molecular docking analysis. Pharmacol Rep. 2021 Dec; 73(6):1765-1780.
-
Facile Synthesis of Ag/AgVO3/N-rGO Hybrid Nanocomposites for Electrochemical Detection of Levofloxacin for Complex Biological Samples Using Screen-Printed Carbon Paste Electrodes. Inorg Chem. 2021 May 03; 60(9):6585-6599.
-
Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019. Anatol J Cardiol. 2021 03; 25(3):184-190.
-
Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV. Viruses. 2020 12 23; 13(1).
-
Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation. Medicina (Kaunas). 2020 Oct 29; 56(11).
-
Neuraxial anaesthesia in the context of bacterial meningitis and COVID-19. Br J Anaesth. 2020 12; 125(6):e488-e490.
-
Legionella pneumonia: increased risk after COVID-19 lockdown? Italy, May to June 2020. Euro Surveill. 2020 07; 25(30).
-
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study. Daru. 2020 Dec; 28(2):507-516.
-
Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19? Arch Med Res. 2020 10; 51(7):741-742.
-
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance. Eur Respir J. 2019 10; 54(4).